Publications by authors named "G Carretero-Hernandez"
Article Synopsis
- A study was conducted on patients with atopic dermatitis (AD) to explore the impact of atopic comorbidities like asthma and allergic rhinitis on their treatment response.
- Data was collected from the BIOBADATOP registry, involving 509 patients, mostly adults with severe AD, and analyzed for associations between atopic comorbidities and clinical characteristics.
- Results indicated that patients with personal atopic comorbidities had more severe symptoms and a higher history of treatments, but no significant differences in treatment response were found after 6 and 12 months, suggesting a need for longer follow-up.
Article Synopsis
- - In 2017, the Spanish Academy of Dermatology created the Minimal Disease Activity (MDA) criteria to assess psoriasis severity, and this study aimed to evaluate its nationwide application across Spain.
- - The study included 830 psoriasis patients, showing that over 59% did not meet MDA criteria, with significant variances observed based on region, sex, age, and treatment type.
- - Results indicated that patients using biological therapies had better MDA compliance compared to those on other treatments, suggesting a need for more effective management of psoriasis across different demographics.
Spanish Autonomous Communities (ACs) are entitled to decide on the prescription requirements of their own territories, which can create inequalities in access to new drugs in the management of psoriasis. The objective of this study was to assess whether the level of restrictions in the access to new drugs for the management psoriasis was associated with the probability of achieving disease control measured using the Minimum Disease Activity (MDA) criteria. Therefore, we combined the results of 2 previous independent, cross-sectional studies: one that described the MDA in psoriasis by AC, and another that evaluated the level of restrictions to drug access by AC.
View Article and Find Full Text PDFBackground: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities.
Material And Methods: Cross-sectional study conducted in April and May, 2023.
Background: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities.
Material And Methods: Cross-sectional study conducted in April and May, 2023.